Related Experiment Videos
Rationale and approaches to constructing preerythrocytic malaria vaccines
1Malaria Program, Naval Medical Research Institute, Bethesda, Maryland 20889-5607, USA.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Low-Frequency Adaptive Deep Brain Stimulation for Parkinson's Disease.
medRxiv : the preprint server for health sciences·2026
Beta Burst-Driven Adaptive Deep Brain Stimulation Improves Gait Impairment and Freezing of Gait in Parkinson's Disease.
medRxiv : the preprint server for health sciences·2024
Live attenuated malaria vaccine designed to protect through hepatic CD8⁺ T cell immunity.
Science (New York, N.Y.)·2011
Pulmonary gas exchange in the morbidly obese.
Obesity reviews : an official journal of the International Association for the Study of Obesity·2008
Cross-protection between attenuated Plasmodium berghei and P. yoelii sporozoites.
Parasite immunology·2007
Fundamentals of freeze-drying.
Pharmaceutical biotechnology·2002
Fundamentals of thermal sterilization processes.
Pharmaceutical biotechnology·2002
Effects of conformation on the chemical stability of pharmaceutically relevant polypeptides.
Pharmaceutical biotechnology·2002
Vitamin B12 transporters.
Pharmaceutical biotechnology·2000
Multidrug-resistance transporters.
Pharmaceutical biotechnology·2000
Nucleoside transporters of mammalian cells.
Pharmaceutical biotechnology·2000
Aptamer-based nanoparticle drug delivery system designed for targeting GPC3-positive liver cancer.
Journal of pharmaceutical analysis·2026
Structure-informed characterization of a TLR2-binding scFv reveals a CDR-centered recognition model.
Biochemical and biophysical research communications·2026
Safety assessment of the substance 1,3-benzenedicarboxamide, 5-[[[cis-4-(1,1-dimethylethyl)cyclohexyl]carbonyl]amino]-N1,N3-bis[cis-4-(1-methylethyl)cyclohexyl]- for use in food contact materials.
EFSA journal. European Food Safety Authority·2026
Systems pharmacology, structural modeling, and experimental validation reveal retinoic acid as a modulator of immune-fibrotic networks in chronic kidney disease.
Naunyn-Schmiedeberg's archives of pharmacology·2026
New paradigm of q-CAR drug development targeting disease-specific protein conformations.
npj drug discovery·2026